Press release Biocartis Group NV: Disclosure of Outstanding Voting Securities
PRESS RELEASE - REGULATED INFORMATION 30 June 2023, 7:00 CEST Disclosure of Outstanding Voting Securities Mechelen, Belgium, 30 June 2023 – Biocartis Group NV (the "Company" or "Biocartis"), an innovative molecular diagnostics company (Euronext Brussels: BCART), today announces that in the course of June 2023 4.50% convertible bonds due 2026 in a principal amount of EUR 495,900 were converted against the issuance of 445,977 shares of the Company. In view hereof, and in accordance with article 15